Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bio-Rad Laboratories Inc
BIO-BCurrent price
326.74 USD
0 USD (0.00%)
Last closed
326.78 USD
Company
www.bio-rad.com
ISIN
US0905721082
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Capitalization
9 175 263 232 USD
Yield for 12 month
-15.69 %
1Y
3Y
5Y
10Y
15Y
BIO-B
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+2 671 262 000 USD
Last Year
+2 802 249 000 USD
Current Quarter
+638 476 000 USD
Last Quarter
+610 820 000 USD
Current Year
+1 431 346 000 USD
Last Year
+1 567 330 000 USD
Current Quarter
+355 719 000 USD
Last Quarter
+326 466 000 USD
Key Figures BIO-B
1 year
3 years
5 years
10 years
EBITDA
514 169 984 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
2.11 %
PEG Ratio
1.2073
Return On Equity TTM
-17.41 %
Wall Street Target Price
–
Revenue TTM
2 562 604 032 USD
Book Value
240.39 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-6.3 %
Dividend Yield
–
Gross Profit TTM
1 568 430 000 USD
Earnings per share
-47.35 USD
Diluted Eps TTM
-47.35 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
479.7 %
Profit Margin
-51.73 %
Dividend Analytics BIO-B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIO-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
08.03.2002
Dividend Date
–
Stock Valuation BIO-B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
29.1545
Enterprise Value Revenue
3.4933
Price Sales TTM
3.5804
Enterprise Value EBITDA
-13.0746
Price Book MRQ
1.3435
Financials BIO-B
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BIO-B
For 52 weeks
268.88 USD
373.79 USD
50 Day MA
307.27 USD
Shares Short Prior Month
116
200 Day MA
308.99 USD
Short Ratio
5.43
Shares Short
76
Short Percent
0.05 %
BeatStart